| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yi Chen, Yaoyao Zhang, Kaili Fan, Weiqian Xu, Chao Teng, Shuangshuang Wang, Wei Tang, Xiaomin Zh. Association between gonadal hormones and osteoporosis in schizophrenia patients undergoing risperidone monotherapy: a cross-sectional study. PeerJ. vol 9. 2021-05-16. PMID:33987015. |
association between gonadal hormones and osteoporosis in schizophrenia patients undergoing risperidone monotherapy: a cross-sectional study. |
2021-05-16 |
2023-08-13 |
Not clear |
| Xujun Duan, Maolin Hu, Xinyue Huang, Chan Su, Xiaofen Zong, Xia Dong, Changchun He, Jinming Xiao, Haoru Li, Jinsong Tang, Xiaogang Chen, Huafu Che. Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia. Schizophrenia bulletin. vol 46. issue 3. 2021-05-14. PMID:31504959. |
effect of risperidone monotherapy on dynamic functional connectivity of insular subdivisions in treatment-naive, first-episode schizophrenia. |
2021-05-14 |
2023-08-13 |
Not clear |
| Xue Li, Xiuxia Yuan, Yulin Kang, Lijuan Pang, Yafei Liu, Qiyue Zhu, Luxian Lv, Xu-Feng Huang, Xueqin Son. A synergistic effect between family intervention and rTMS improves cognitive and negative symptoms in schizophrenia: A randomized controlled trial. Journal of psychiatric research. vol 126. 2021-05-14. PMID:32428747. |
the present study explored an efficient new therapy that combined repetitive transcranial magnetic stimulation (rtms) and family intervention in addition to risperidone to improve schizophrenia. |
2021-05-14 |
2023-08-13 |
Not clear |
| Seokmin Noh, Euihyeon Na, Se Jin Park, Seok Hyeon Kim, A Eden Evins, Sungwon Ro. Effects of various antipsychotics on driving-related cognitive performance in adults with schizophrenia. Journal of psychiatric research. vol 131. 2021-05-14. PMID:32971359. |
in this cross-sectional design study, adults with schizophrenia treated with aripiprazole or paliperidone antipsychotic monotherapy demonstrated superior driving-related cognitive performance than those treated with haloperidol or risperidone antipsychotic monotherapy. |
2021-05-14 |
2023-08-13 |
human |
| Wallace Breno Barbosa, Rosângela Maria Gomes, Brian Godman, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnio. Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications. Expert review of clinical pharmacology. vol 14. issue 2. 2021-04-29. PMID:33331189. |
real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in brazil over a 16-year follow-up period; findings and implications. |
2021-04-29 |
2023-08-13 |
Not clear |
| Jinjun Lu, Ye Yang, Jian Lu, Zuqing Wang, Yiping He, Yeliang Yan, Kai Fu, Wenjuan Jiang, Yunqing Xu, Renrong Wu, Wenqing Liu, Jingping Zha. Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone. BMC psychiatry. vol 21. issue 1. 2021-04-26. PMID:33535976. |
this study aimed to investigate the influence of cyp2d6 polymorphisms on risperidone plasma concentrations in patients with schizophrenia. |
2021-04-26 |
2023-08-13 |
Not clear |
| Hsiao-Pei Tsai, Po-Hsun Hou, Frank-Chiahung Mao, Chia-Chia Chang, Wei-Cheng Yang, Ching-Feng Wu, Huei-Jyuan Liao, Tzu-Chun Lin, Lan-Szu Chou, Li-Wei Hsiao, Geng-Ruei Chan. Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. International journal of molecular sciences. vol 22. issue 1. 2021-04-13. PMID:33401717. |
risperidone, a second-generation antipsychotic drug used for schizophrenia treatment with less-severe side effects, has recently been applied in major depressive disorder treatment. |
2021-04-13 |
2023-08-13 |
mouse |
| Belen Arranz, Marina Garriga, Miquel Bernardo, Ana Gonzalez-Pinto, Manuel Arrojo, Marta Torrens, Judith Tirado-Muñoz, Francina Fonseca, Pilar A Saiz, Gerardo Florez, Jose Manuel Goikolea, Iñaki Zorrilla, Ruth Cunill, Xavi Castells, Elisardo Becoña, Ana Lopez, Luis Sa. Clinical Practice Guideline on Pharmacological and Psychological management of adult patients with Schizophrenia Spectrum Disorders and a comorbid substance use. Adicciones. vol 0. issue 0. 2021-03-26. PMID:33768260. |
our results suggest: 1) in patients with schizophrenia and cannabis use disorder, it is not possible to recommend one antipsychotic drug over another (between olanzapine, risperidone or haloperidol) for improving psychotic symptoms, reducing cannabis use, or improving pragmatic variables (weak recommendation). |
2021-03-26 |
2023-08-13 |
Not clear |
| Wang Zhenhua, Chen Haizhi, Li Jing, Fei Xiaocong, Li Jianhua, Liu Jianjun, Lei Lilei, Jin Haiyin. Occurrence of macroprolactinemia in schizophrenia patients treated with risperidone or amisulpride. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists. 2021-03-23. PMID:33754473. |
occurrence of macroprolactinemia in schizophrenia patients treated with risperidone or amisulpride. |
2021-03-23 |
2023-08-13 |
Not clear |
| Liroy Lugasi, Igor Grinberg, Rivka Sabag, Ravit Madar, Haim Einat, Shlomo Marge. Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone. Molecules (Basel, Switzerland). vol 25. issue 17. 2021-03-10. PMID:32887463. |
risperidone (rsp) is an atypical antipsychotic drug widely used to treat schizophrenia and bipolar disorder. |
2021-03-10 |
2023-08-13 |
mouse |
| Rituparna Maiti, Biswa Ranjan Mishra, Monalisa Jena, Archana Mishra, Santanu Nat. Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 19. issue 1. 2021-02-28. PMID:33508796. |
effect of haloperidol and risperidone on serum melatonin and gap-43 in patients with schizophrenia: a prospective cohort study. |
2021-02-28 |
2023-08-13 |
Not clear |
| Rituparna Maiti, Biswa Ranjan Mishra, Monalisa Jena, Archana Mishra, Santanu Nat. Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 19. issue 1. 2021-02-28. PMID:33508796. |
the present study was conducted to investigate the adequacy of the first-line antipsychotic drugs to improve sleep and circadian rhythm disruptions by assessing the effect of haloperidol and risperidone on serum melatonin and gap-43 in schizophrenia. |
2021-02-28 |
2023-08-13 |
Not clear |
| Anna Dietrich-Muszalska, Joanna Kolodziejczyk-Czepas, Pawel Nowa. Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients. Neuropsychiatric disease and treatment. vol 17. 2021-02-26. PMID:33628026. |
therefore, in the present study, we assessed the ability of six atypical ads (clozapine, olanzapine, quetiapine, risperidone, aripiprazole, and ziprasidone) used in schizophrenia treatment to modulate oxidative damage to different biomolecules such as lipids and proteins. |
2021-02-26 |
2023-08-13 |
Not clear |
| Nishant Sharma, Sangeeta Bhat, Divya Ravi, Pius Ochien. Severe hypothermia, bradycardia and cardiac arrest in association with risperidone. BMJ case reports. vol 13. issue 5. 2021-02-08. PMID:32439747. |
antipsychotic medications, including risperidone, are widely used in the treatment of psychiatric disorders, including schizophrenia. |
2021-02-08 |
2023-08-13 |
Not clear |
| Wenjuan Yu, Lei Lei, Yimin Yu, Yan Li, Yifeng Shen, Huafang L. Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study. Human psychopharmacology. vol 35. issue 1. 2021-02-05. PMID:31837240. |
model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: a randomized double-blind study. |
2021-02-05 |
2023-08-13 |
Not clear |
| Wenjuan Yu, Lei Lei, Yimin Yu, Yan Li, Yifeng Shen, Huafang L. Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study. Human psychopharmacology. vol 35. issue 1. 2021-02-05. PMID:31837240. |
this study examined randomized controlled trial data for blonanserin and risperidone in chinese schizophrenia patients (n = 264). |
2021-02-05 |
2023-08-13 |
Not clear |
| Ghassan A Alkharboush, Majid A Alsalama. Risperidone-Induced Acute Laryngeal Dystonia: A Case Report. The American journal of case reports. vol 21. 2021-01-28. PMID:32506071. |
case report a 27-year-old woman with schizophrenia on risperidone presented to our emergency department with a sensation of choking and respiratory distress, mimicking a panic attack. |
2021-01-28 |
2023-08-13 |
Not clear |
| Herbert Y Meltzer, Daniel B Share, Karu Jayathilake, Ronald M Salomon, Myung A Le. Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. vol 40. issue 3. 2021-01-13. PMID:32332459. |
in addition to clozapine, other atypical antipsychotic drugs pharmacologically similar to clozapine, for example, olanzapine, risperidone, and melperone, are also effective in a similar proportion of treatment-resistant schizophrenia (trs) patients, ~40%. |
2021-01-13 |
2023-08-13 |
Not clear |
| Shaoqiang Han, Benjamin Becker, Xujun Duan, Qian Cui, Fei Xin, Xiaofen Zong, Maolin Hu, Mi Yang, Rong Li, Yangyang Yu, Wei Liao, Xiaogang Chen, Huafu Che. Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophrenia research. vol 215. 2021-01-11. PMID:31759811. |
distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. |
2021-01-11 |
2023-08-13 |
Not clear |
| Shaoqiang Han, Benjamin Becker, Xujun Duan, Qian Cui, Fei Xin, Xiaofen Zong, Maolin Hu, Mi Yang, Rong Li, Yangyang Yu, Wei Liao, Xiaogang Chen, Huafu Che. Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophrenia research. vol 215. 2021-01-11. PMID:31759811. |
to this end, treatment-naive first-episode schizophrenia patients (n = 41) underwent task-free resting-state fmri assessment before (baseline) and after 8 weeks of risperidone monotherapy (n = 38). |
2021-01-11 |
2023-08-13 |
Not clear |